Team:ATOMS-Turkiye
From 2014.igem.org
m |
m |
||
Line 13: | Line 13: | ||
<h1 >The Change of HEART </h1> | <h1 >The Change of HEART </h1> | ||
<p>Your team has been approved and you are ready to start the iGEM season! | <p>Your team has been approved and you are ready to start the iGEM season! | ||
- | <br> | + | <br>Tissue hypoxia, or ischemia, is the condition that describes the poor conveyance of oxygen and |
+ | |||
+ | other vital products to body tissues and organs which consequently results tissue death. Up to now, | ||
+ | |||
+ | the number one cause of death worldwide is caused by ischemia and related conditions such as | ||
+ | |||
+ | heart attack or stroke. Additionally, due to the remarkable damage to tissues, these diseases end | ||
+ | |||
+ | up with high morbidity rates. From pharmacology to biomedical industry, variety of prevention and | ||
+ | |||
+ | treatment options have been suggested, many of them have still being applied. Nevertheless, we | ||
+ | |||
+ | still have not reached the very end of cure and more novel approaches from different fields may play | ||
+ | |||
+ | great role for this reason. One of these approaches is, of course, synthetic biology. The benefits of | ||
+ | |||
+ | SynBio allow us to manipulate micro and nano scales of cell environment in order to involve in when | ||
+ | |||
+ | the action starts and to interfere at the right time. | ||
+ | |||
+ | Ischemic damage is related with two different phenomena. First, the vital blood supply that carry | ||
+ | |||
+ | oxygen, energy gathering nutrition and other minerals is cut down by an external effect, mostly by | ||
+ | |||
+ | a clot. Afterwards, cells become unable to produce enough energy and start wasting their deployed | ||
+ | |||
+ | nutrition in a different reaction cascade that results with building up toxic chemicals in the media. | ||
+ | |||
+ | If the clot barrier is removed, excessive oxygen presence in the media may enhance this toxic | ||
+ | |||
+ | production because of high metabolic rate of the cells. These toxic products, also known as reactive | ||
+ | |||
+ | oxygen species (ROS), may increase the cell damage further. Thus, it is needed to regard the big | ||
+ | |||
+ | picture of the condition In order to solve the problem. | ||
+ | |||
+ | In our project, our will is to build two different devices, which work synergistically, to fix these two | ||
+ | |||
+ | distinct situations. To do this, we aim to design hypoxia inducible systems, which is the first step for | ||
+ | |||
+ | constructing a sensitive and robust device. Hypoxia inducible promoters and their regulator proteins | ||
+ | |||
+ | are responsible for this critical mission. Beside of this, we also want to prevent the damage caused | ||
+ | |||
+ | by reperfusion of blood to the hypoxic environment, we also need an additional sensitive receptor | ||
+ | |||
+ | construct. After our researches, we decided to use reactive oxygen species (ROS) sensitive promoter | ||
+ | |||
+ | systems. These two receptors will hopefully regulate the release of clot dissolving factors synthesized | ||
+ | |||
+ | by our engineered vessel cells. Moreover, we hope to maximize the reduction of ROS damage to the | ||
+ | |||
+ | cells by producing antioxidant enzymes to degrade ROS within the cells. By re-providing vital oxygen | ||
+ | |||
+ | support via bloodstream and enhancing the degradation of ROS in the tissue, this project intends to | ||
+ | |||
+ | propose a new treatment approach for ischemia related diseases. | ||
+ | |||
+ | In the future, following the advancements in gene therapy and cell therapy industries, we would | ||
+ | |||
+ | like to implement our system in living models. Especially, tissue engineered heart vessel cells or | ||
+ | |||
+ | manipulating the whole body by gene containing exosomes, this treatment option may also pose an | ||
+ | |||
+ | alternative prevention method for ischemic heart attack or strokes. We hope to bring encouraging | ||
+ | |||
+ | results in vitro to pave the way of this promising system into the lifesaving remedy method. <br> and share your iGEM experience with the rest of the world! </p> | ||
<br> | <br> | ||
<p style="color:#E7E7E7"> <a href="https://2014.igem.org/wiki/index.php?title=Team:ATOMS-Turkiye&action=edit"style="color:#FFFFFF"> Click here to edit this page!</a> </p> | <p style="color:#E7E7E7"> <a href="https://2014.igem.org/wiki/index.php?title=Team:ATOMS-Turkiye&action=edit"style="color:#FFFFFF"> Click here to edit this page!</a> </p> |
Revision as of 11:29, 2 August 2014
The Change of HEARTYour team has been approved and you are ready to start the iGEM season!
|
||||||||||||
| ||||||||||||
Requirements | ||||||||||||
Please be sure to keep these links, your audience will want to find your: |
There are a few wiki requirements teams must follow:
Visit the Wiki How To page for a complete list of requirements, tips and other useful information. |
|||||||||||
Tips | ||||||||||||
We are currently working on providing teams with some easy to use design templates.
For a full wiki list, you can visit iGEM 2013 web sites and iGEM 2012 web sites lists. |
This wiki will be your team’s first interaction with the rest of the world, so here are a few tips to help you get started:
|